Pathogenesis of acute coronary syndromes.

[1]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[2]  A. Davies,et al.  Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. , 2012, European heart journal.

[3]  I. Loftus,et al.  High Levels of Costimulatory Receptors OX40 and 4-1BB Characterize CD4+CD28null T Cells in Patients With Acute Coronary Syndrome , 2012, Circulation research.

[4]  Akiko Maehara,et al.  Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes. , 2012, JACC. Cardiovascular imaging.

[5]  E. Braunwald.  Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. , 2012, European heart journal.

[6]  W. R. Taylor,et al.  Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[7]  B. Gersh.  3-Year Follow-Up of Patients With Coronary Artery Spasm as Cause of Acute Coronary Syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study Follow-Up , 2012 .

[8]  J. Kastelein,et al.  Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial , 2012, Cardiovascular Drugs and Therapy.

[9]  F. Crea,et al.  High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. , 2011, Journal of the American College of Cardiology.

[10]  C. Pepine,et al.  Microvascular dysfunction: what have we learned from WISE? , 2011, Expert review of cardiovascular therapy.

[11]  F. Crea,et al.  Anti-inflammatory treatment of acute coronary syndromes. , 2011, Current pharmaceutical design.

[12]  Chunhong Ma,et al.  IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. , 2011, Clinical immunology.

[13]  F. Crea,et al.  Contemporary Reviews in Cardiovascular Medicine Mechanisms of Coronary Artery Spasm , 2011 .

[14]  T. Lüscher,et al.  Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes. , 2011, Atherosclerosis.

[15]  D. Wood,et al.  Mechanisms of Myocardial Infarction in Women Without Angiographically Obstructive Coronary Artery Disease , 2011, Circulation.

[16]  Deepak L. Bhatt,et al.  Apixaban with antiplatelet therapy after acute coronary syndrome. , 2011, The New England journal of medicine.

[17]  J. Freedman,et al.  Regulatory effects of TLR2 on megakaryocytic cell function. , 2011, Blood.

[18]  F. Crea,et al.  Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. , 2011, European heart journal.

[19]  Mitsuaki Isobe,et al.  In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. , 2011, European heart journal.

[20]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[21]  W. Wongcharoen,et al.  Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. , 2011, European heart journal.

[22]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[23]  Deepak L. Bhatt,et al.  APPRAISE 2. Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome for the APPRAISE-2 Investigators* , 2011 .

[24]  R. Virmani,et al.  Response to Letter Regarding Article, “High Levels of Systemic Myeloperoxidase Are Associated With Coronary Plaque Erosion in Patients With Acute Coronary Syndromes: A Clinicopathological Study” , 2011 .

[25]  P. Kovanen,et al.  Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation , 2010, PloS one.

[26]  D. Newby.  Triggering of acute myocardial infarction: beyond the vulnerable plaque , 2010, Heart.

[27]  Andrew D. Johnson,et al.  Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study , 2010, Circulation.

[28]  R. Virmani,et al.  Concept of vulnerable/unstable plaque. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Carl J Pepine,et al.  Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, Journal of the American College of Cardiology.

[30]  A. Rebuzzi,et al.  Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome. , 2010, European heart journal.

[31]  F. Crea,et al.  Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management , 2010, Circulation.

[32]  I. Mitroulis,et al.  Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome. , 2010, European journal of internal medicine.

[33]  Hong Wang,et al.  Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. , 2010, Frontiers in bioscience.

[34]  F. Eberli,et al.  Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. , 2010, European heart journal.

[35]  G. Biondi-Zoccai,et al.  Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). , 2010, The American journal of cardiology.

[36]  Shuang Chen,et al.  Emerging Role of IL-17 in Atherosclerosis , 2010, Journal of Innate Immunity.

[37]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[38]  J. Kaski,et al.  C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it? , 2010, European heart journal.

[39]  Hiroto Tsujioka,et al.  Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. , 2010, The American journal of cardiology.

[40]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[41]  V. Kuchroo,et al.  Interleukin-17 and type 17 helper T cells. , 2009, The New England journal of medicine.

[42]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[43]  F. Crea,et al.  Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability. , 2009, European heart journal.

[44]  T. Akasaka,et al.  Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[45]  P. Libby,et al.  Monocyte Subset Dynamics in Human Atherosclerosis Can Be Profiled with Magnetic Nano-Sensors , 2009, PloS one.

[46]  K. Aziz,et al.  Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. , 2009, The American journal of cardiology.

[47]  G. Szot,et al.  Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes , 2009, Diabetes.

[48]  J. Freedman,et al.  Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase , 2009, Circulation research.

[49]  M. Cheitlin.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2009 .

[50]  J. Kaski,et al.  CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. , 2009, Cardiovascular research.

[51]  A. Maseri,et al.  Expansion of T-Cell Receptor &zgr;dim Effector T Cells in Acute Coronary Syndromes , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[52]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[53]  J. Kaski,et al.  Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome. , 2008, European heart journal.

[54]  J. Danesh,et al.  C‐reactive protein and coronary heart disease: a critical review , 2008, Journal of internal medicine.

[55]  Frits Mastik,et al.  Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque , 2008, Circulation.

[56]  P. Libby,et al.  Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. , 2008, Circulation.

[57]  J. Bluestone,et al.  Human regulatory T cells: role in autoimmune disease and therapeutic opportunities , 2008, Immunological reviews.

[58]  Yong Chen,et al.  The Th17/Treg imbalance in patients with acute coronary syndrome. , 2008, Clinical immunology.

[59]  K. Klingel,et al.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2008, Heart.

[60]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[61]  G. Niccoli,et al.  High telomerase activity in neutrophils from unstable coronary plaques. , 2007, Journal of the American College of Cardiology.

[62]  M. Shin,et al.  Synergistic Proinflammatory Effects of the Antiviral Cytokine Interferon-&agr; and Toll-Like Receptor 4 Ligands in the Atherosclerotic Plaque , 2007, Circulation.

[63]  A. Rebuzzi,et al.  Unusual CD4+CD28nullT Lymphocytes and Recurrence of Acute Coronary Events , 2007 .

[64]  Peng Liu,et al.  The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. , 2007, Clinical immunology.

[65]  F. Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[66]  J. Kaski,et al.  Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? , 2007, Journal of the American College of Cardiology.

[67]  B. Gersh,et al.  Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? , 2007, European heart journal.

[68]  P. Libby,et al.  Intertwining of thrombosis and inflammation in atherosclerosis , 2007, Current opinion in hematology.

[69]  W. Frishman.  Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque: Evidence for a Local, Intracoronary Immunologic Mechanism , 2007 .

[70]  G. Lip,et al.  A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. , 2007, Thrombosis research.

[71]  A. Rebuzzi,et al.  Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. , 2007, Journal of the American College of Cardiology.

[72]  G. Keren,et al.  Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. , 2006, European heart journal.

[73]  R. Bugiardini,et al.  Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. , 2006, Archives of internal medicine.

[74]  Kayoko Sato,et al.  T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome , 2006, Circulation research.

[75]  J. Kaski,et al.  Cardiac syndrome X in women: the role of oestrogen deficiency , 2006, Heart.

[76]  R. Frye,et al.  Interleukin 12 Induces T-Cell Recruitment Into the Atherosclerotic Plaque , 2006, Circulation research.

[77]  M. Chiariello,et al.  Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque: Evidence for a Local, Intracoronary Immunologic Mechanism , 2006, Circulation.

[78]  R. Flavell,et al.  Natural regulatory T cells control the development of atherosclerosis in mice , 2006, Nature Medicine.

[79]  A. Takeshita,et al.  Rho-kinase is an important therapeutic target in cardiovascular medicine. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[80]  T. van der Poll,et al.  Two-way interactions between inflammation and coagulation. , 2005, Trends in cardiovascular medicine.

[81]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[82]  P. Serruys,et al.  The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications , 2005, Nature Clinical Practice Cardiovascular Medicine.

[83]  M. Thomas.  Are drug eluting stents really worth the money? , 2005, Heart.

[84]  P. Libby.  Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. , 2005, Journal of the American College of Cardiology.

[85]  K. Shimada,et al.  Multiple plaque rupture and C-reactive protein in acute myocardial infarction. , 2005, Journal of the American College of Cardiology.

[86]  Elena Bonanno,et al.  Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. , 2005, Journal of the American College of Cardiology.

[87]  C Noel Bairey Merz,et al.  Angina with "normal" coronary arteries. , 2005 .

[88]  R. Hubbard,et al.  Risk of myocardial infarction and stroke after acute infection or vaccination. , 2004, The New England journal of medicine.

[89]  S. Nissen.  High-dose statins in acute coronary syndromes: not just lipid levels. , 2004, JAMA.

[90]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[91]  J. Kaski,et al.  Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes , 2004, Heart.

[92]  Qingbo Xu,et al.  Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes , 2004, Circulation.

[93]  K. Klingel,et al.  Parvovirus B19 Infection Mimicking Acute Myocardial Infarction , 2003, Circulation.

[94]  F. Crea,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.

[95]  R. Frye,et al.  T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes , 2002, Circulation.

[96]  A. Maseri,et al.  Evidence for Antigen-Driven T-Cell Response in Unstable Angina , 2000, Circulation.

[97]  R. Frye,et al.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.

[98]  R. Frye,et al.  Perturbation of the T-cell repertoire in patients with unstable angina. , 1999, Circulation.

[99]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.